Latest filing published 17 Jun 2026 for Alector, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Altmeyer: trading record in brief
This profile gathers the share dealings of Mark Altmeyer across 3 companies, led by Alector, Inc., Myovant Sciences Ltd. and Sio Gene Therapies Inc. We count 5 filings; the first trade dates from 10 March 2016 and the latest from 17 June 2026.
The open-market record is one-sided, with 2 purchases worth €63k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants.
Most recently, on 17 June 2026, the filings show a share grant in Alector, Inc. The clock since the last published purchase (15 June 2018) now reads 3,068 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Altmeyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,700 sharesCommon StockSEC:0001193125-26-274124:0
- 28,700 shares0Common StockSEC:0000950170-25-085614:0
- 41,250 shares0Common StockSEC:0000950170-24-034849:0
- 3,500 shares@ US$13.38100.0% of flowCommon SharesSEC:0001209191-18-038121:0Canonical exit: 15 Feb 2018 (T+90)
- 2,300 shares@ US$11.14100.0% of flowCommon SharesSEC:0001643074-16-000003:0Canonical exit: 8 Jun 2016 (T+90)
5 of 5 declarations
